Pressure waveform analysis for occlusion assessment significantly reduces contrast medium use in cryoballoon pulmonary vein isolation
-
Published:2024-04-17
Issue:
Volume:
Page:
-
ISSN:1572-8595
-
Container-title:Journal of Interventional Cardiac Electrophysiology
-
language:en
-
Short-container-title:J Interv Card Electrophysiol
Author:
Sciacca Vanessa, Fink Thomas, Winnik Stephan, Hamriti Mustapha El, Guckel Denise, Didenko Maxim, Mörsdorf Maximilian, Braun Martin, Khalaph Moneeb, Imnadze Guram, Sommer Philipp, Sohns ChristianORCID
Abstract
Abstract
Background
Pulmonary vein (PV) occlusion is crucial for adequate lesion formation during cryoballoon-guided pulmonary vein isolation (CB-PVI). PV occlusion is usually confirmed by angiographies over the inflated balloon device. The aim of our study was to analyze the safety and efficacy of pressure waveform-based PV occlusion assessment during CB-PVI utilizing a novel fully integrated pressure analysis tool.
Methods
Consecutive patients with symptomatic atrial fibrillation (AF) scheduled for CB-PVI were prospectively enrolled for pressure waveform-based PV occlusion assessment. A patient cohort receiving conventional angiographies served as control group. Patients with common PV ostia were excluded.
Results
The study group consisted of 40 patients (16 females, mean age was 64.5 ± 9.7, 45% persistent AF). The control group consisted of 40 matched patients. All 160 PVs in the study group were successfully isolated without the use of additional venograms confirming PV occlusion. The mean procedure duration was 69 ± 12 min in the study group with a mean fluoroscopy duration of 11.5 ± 4.4 min. The mean contrast medium volume was 22 ± 9 ml in the study group and 36 ± 12 ml in the control group (p = 0.0001). Mean procedure duration, mean balloon temperatures, and mean ablation application durations did not differ significantly between the study and the control group. No periprocedural complications occurred.
Conclusion
CB-PVI utilizing a fully integrated pressure waveform analysis tool to assess PV occlusion is feasible and safe and significantly reduces the amount of contrast medium without impact on procedural parameters and freedom from arrhythmia recurrence.
Graphical Abstract
Funder
Ruhr-Universität Bochum
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373-498. https://doi.org/10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42:507. Erratum in: Eur Heart J. 2021;42:546-547. Erratum in: Eur Heart J. 2021;42:4194. 2. Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45. https://doi.org/10.1056/NEJMoa1602014. 3. Kosmidou I, Wooden S, Jones B, Deering T, Wickliffe A, Dan D. Direct pressure monitoring accurately predicts pulmonary vein occlusion during cryoballoon ablation. J Vis Exp. 2013;72:e50247. 4. Raizada A, Gedela M, Shaikh KA, Apte N, DeHaan M, Stanton C. Pressure-guided cryoablation of pulmonary veins in atrial fibrillation: a fast and effective strategy. Indian Heart J. 2017;69(2):223–5. 5. De Simone A, La Rocca V, Agresta A, Maiorino M, Malacrida M, Ricciolino R. Pressure guided pulmonary vein isolation by means of a novel cryoballoon technology for the management of complex anatomy: a case report. HeartRhythm Case Rep. 2023;9(8):569–72.
|
|